用富途牛牛查看vTv Therapeutics (VTVT)的股票价格、新闻、历史走势图、分析师评级、财务信息和行情。使用富途牛牛免佣金股票交易App进行交易。
[vTv Therapeutics, Inc. Class A]在美东时间7月26日16:01:47停牌,原因是有消息未披露。停牌后恢复交易的时间为7月26日16:30:00。 同花顺 11-20 14:11 交易提示:vTv Therapeutics宣布2023年11月21日并股 [vTv Therapeutics, Inc. Class A] will perform a stock split on November 21, 2023, dividing...
VTv Therapeutics stock is premarket's most active with 2.4 mln shares traded Feb. 10, 2020 at 8:22 a.m. ETby Tomi Kilgore VTv Therapeutics stock rockets 87% toward 16-mo. high after positive trial data from diabetes treatment Feb. 10, 2020 at 8:21 a.m. ETby Tomi Kilgore ...
手机东方财富网是东方财富网的手机门户网站,为亿万用户打造一个手机联通世界的超级平台,提供7*24小时全面及时的财经中文资讯,内容覆盖国内外突发事件、股市资讯、全球新闻、产业资讯、实用信息等。手机东方财富网触屏版 - eastmoney.com
Use Futu NiuNiu to view vTv Therapeutics (VTVT)'s stock price, real-time quotes, latest news, historical trend charts, financial information and quotes.
手机东方财富网是东方财富网的手机门户网站,为亿万用户打造一个手机联通世界的超级平台,提供7*24小时全面及时的财经中文资讯,内容覆盖国内外突发事件、股市资讯、全球新闻、产业资讯、实用信息等。手机东方财富网触屏版 - eastmoney.com
VTVT vTv Therapeutics Inc. Class A Common Stock Reload Interactive Chart to its default setting. [ Note: Use the Chart Header to configure the chart style and default settings.] Reset to Default Comparison Controls Select either a single symbol or "all" to Compare To (15 Max.) the selected...
Hedge Funds Weigh In On vTv Therapeutics An institutional investor recently bought a new position in vTv Therapeutics stock. FMR LLC bought a new position in vTv Therapeutics Inc. ( NASDAQ:VTVT – Free Report ) in the third quarter, according to the company in its most recent Form 13F ...
03/13/2024 08:00 AM EDTGlobeNewswirevTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update Date/TimeSourceNews Release 12/18/2024 10:24 PM ESTStock Traders DailyWhere are the Opportunities in (VTVT) ...
Participate in the 2025 Stockpicking Contest Long or short five stocks and compete to have the highest return by the end of the year. Choose your picks About the company vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development of orally administered treatments...